The global academic distribution and changes in research hotspots of artificial intelligence in inflammatory bowel disease since 2000

2000年以来全球学术分布及炎症性肠病人工智能研究热点的变化

阅读:2

Abstract

BACKGROUND: Artificial intelligence (AI) has gained widespread attention because of its potential applications in the clinical management of inflammatory bowel disease (IBD). However, bibliometric analyses of the literature published in this field are currently lacking. This study aimed to characterize the development trends and identify research hotspots in the application of AI to IBD through a bibliometric approach. METHODS: Literature related to the application of AI in IBD, published between 2000 and 2024, was retrieved from the Web of Science Core Collection. Microsoft Office Excel 2021 was used to analyze and visualize the annual number of publications. Charticulator was utilized to create country cross chord charts. CiteSpace was employed to visualize collaboration networks among authors, institutions, and countries, generate timeline visualizations and perform a burst analysis of references and keywords. RESULTS: The bibliometric analysis included 1,136 publications published between the years 2000 and 2024. The number of annual publications showed a rapid growth trend. The USA (n = 337) and Harvard University (n = 47) had the most published papers. Stidham, Ryan (n = 21) published the highest number of articles. The core journals shaping the field included Scientific Reports, Inflammatory Bowel Diseases, and PLoS One. The timeline view and burst analysis of references and keywords revealed that the research hotspots focused on radiomics, endoscopy, natural language processing (NLP), and personalized medicine after 2020. CONCLUSION: A growing number of researchers have engaged in exploring the application of AI in IBD, with the USA contributing the most to this field. Currently, the research hotspots mainly involve radiomics, endoscopy, NLP, and personalized medicine. This study provides valuable information for researchers evaluating the application of AI in IBD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。